P426: HDAC INHIBITORS RESTORE SENSITIVITY TO VENETOCLAX AND NAVITOCLAX IN AML CELLS RESULTING IN THE IRREVERSIBLE DNA DAMAGE

por Khabusheva, Elmira, Tambe, Mahesh, Miettinen, Juho, Heckman, Caroline
Publicado 2023

Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel

por Tambe, Mahesh, Pruikkonen, Sofia, Mäki-Jouppila, Jenni, Chen, Ping, Elgaaen, Bente Vilming, Straume, Anne Hege, Huhtinen, Kaisa, Cárpen, Olli, Lønning, Per Eystein, Davidson, Ben, Hautaniemi, Sampsa, Kallio, Marko J.
Publicado 2016